Cargando…

MiR-148a inhibits oral squamous cell carcinoma progression through ERK/MAPK pathway via targeting IGF-IR

Objective: The current study aimed to investigate the functional roles and clinical significance of microRNA-148a (miR-148a) in the progression of oral squamous cell carcinoma (OSCC). Methods: Relative expression of miR-148a in OSCC cells and tissues were detected using quantitative real-time polyme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jia, Tingting, Ren, Yipeng, Wang, Fengze, Zhao, Rui, Qiao, Bo, Xing, Lejun, Ou, Long, Guo, Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd. 2020
Materias:	Cancer
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174276/ https://www.ncbi.nlm.nih.gov/pubmed/32202300 http://dx.doi.org/10.1042/BSR20182458

Ejemplares similares

Knockdown of LncRNA PANDAR by CRISPR-dCas9 Decreases Proliferation and Increases Apoptosis in Oral Squamous Cell Carcinoma
por: Jia, Tingting, et al.
Publicado: (2021)

miR‐148b inhibits glycolysis in gastric cancer through targeting SLC2A1
por: Ding, Xiangfu, et al.
Publicado: (2017)

HOTAIRM1 competed endogenously with miR‐148a to regulate DLGAP1 in head and neck tumor cells
por: Zheng, Mei, et al.
Publicado: (2018)

LINC00978 promotes hepatocellular carcinoma carcinogenesis partly via activating the MAPK/ERK pathway
por: Zhang, Quan, et al.
Publicado: (2020)

MiR-148a impairs Ras/ERK signaling in B lymphocytes by targeting SOS proteins
por: Alles, Julia, et al.
Publicado: (2017)

Diagnostic and prognostic potential of miR-21, miR-29c, miR-148 and miR-203 in adenocarcinoma and squamous cell carcinoma of esophagus
por: Hezova, Renata, et al.
Publicado: (2015)

MiR-182 regulates cell proliferation and apoptosis in laryngeal squamous cell carcinoma by targeting the CRR9
por: Lv, Yuan, et al.
Publicado: (2019)

ANGPTL3 is a novel biomarker as it activates ERK/MAPK pathway in oral cancer
por: Koyama, Tomoyoshi, et al.
Publicado: (2015)

miR-148 Regulates Mitf in Melanoma Cells
por: Haflidadóttir, Benedikta S., et al.
Publicado: (2010)

Erianin suppresses hepatocellular carcinoma cells through down-regulation of PI3K/AKT, p38 and ERK MAPK signaling pathways
por: Yang, Liang, et al.
Publicado: (2020)

MiR‐634 sensitizes glioma cells to temozolomide by targeting CYR61 through Raf‐ERK signaling pathway
por: Tan, Zhigang, et al.
Publicado: (2018)

Nomogram predicting long-term overall survival and cancer-specific survival of lip carcinoma patients based on the SEER database: A retrospective case–control study
por: Zhao, Rui, et al.
Publicado: (2019)

MiR-942 regulates the function of breast cancer cell by targeting FOXA2
por: Zhang, Jinku, et al.
Publicado: (2019)

IGF-IR promotes clonal cell proliferation in myelodysplastic syndromes via inhibition of the MAPK pathway
por: He, Qi, et al.
Publicado: (2020)

miR-148 family members are putative biomarkers for sepsis
por: Dong, Lei, et al.
Publicado: (2019)

ERK1/2 inhibitors act as monovalent degraders inducing ubiquitylation and proteasome-dependent turnover of ERK2, but not ERK1
por: Balmanno, Kathryn, et al.
Publicado: (2023)

LncRNA XIST promotes the progression of laryngeal squamous cell carcinoma via sponging miR-125b-5p to modulate TRIB2
por: Liu, Chunxiu, et al.
Publicado: (2020)

miR-154-3p and miR-487-3p synergistically modulate RHOA signaling in the carcinogenesis of thyroid cancer
por: Fan, Xiang-da, et al.
Publicado: (2020)

miR-203 inhibits cell proliferation and ERK pathway in prostate cancer by targeting IRS-1
por: Meng, Yang, et al.
Publicado: (2020)

MiR‐24 enhances radiosensitivity in nasopharyngeal carcinoma by targeting SP1
por: Kang, Min, et al.
Publicado: (2016)

Circulating miR-148b and miR-133a as biomarkers for breast cancer detection
por: Shen, Jie, et al.
Publicado: (2014)

Down-regulating NEAT1 inhibited the viability and vasculogenic mimicry formation of sinonasal squamous cell carcinoma cells via miR-195-5p/VEGFA axis
por: Lu, Honglue, et al.
Publicado: (2020)

IGF-IR signaling in epithelial to mesenchymal transition and targeting IGF-IR therapy: overview and new insights
por: Li, Heming, et al.
Publicado: (2017)

MiR-148a inhibits angiogenesis by targeting ERBB3()
por: Yu, Jing, et al.
Publicado: (2011)

miR‐148a suppresses inflammation in lipopolysaccharide‐induced endometritis
por: Jiang, Kangfeng, et al.
Publicado: (2019)

Long non-coding RNA SNHG16 regulates cell behaviors through miR-542-3p/HNF4α axis via RAS/RAF/MEK/ERK signaling pathway in pediatric neuroblastoma cells
por: Deng, Defeng, et al.
Publicado: (2020)

ERK3/MAPK6 dictates CDC42/RAC1 activity and ARP2/3-dependent actin polymerization
por: Bogucka-Janczi, Katarzyna, et al.
Publicado: (2023)

Chicken miR-148a-3p regulates immune responses against AIV by targeting the MAPK signalling pathway and IFN-γ
por: Vu, Thi Hao, et al.
Publicado: (2023)

MIR22HG regulates miR-486/PTEN axis in bladder cancer to promote cell proliferation
por: Tang, Qisheng, et al.
Publicado: (2020)

LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR‐184 expression
por: Fang, Zheng, et al.
Publicado: (2017)

MiR‐375/SLC7A11 axis regulates oral squamous cell carcinoma proliferation and invasion
por: Wu, Yadong, et al.
Publicado: (2017)

Lumican mediates HTB94 chondrosarcoma cell growth via an IGF-IR/Erk1/2 axis
por: Papoutsidakis, Antonis, et al.
Publicado: (2020)

miR-219-5p targets TBXT and inhibits breast cancer cell EMT and cell migration and invasion
por: Ye, Qin, et al.
Publicado: (2021)

Altered expression of miR-152 and miR-148a in ovarian cancer is related to cell proliferation
por: Zhou, Xin, et al.
Publicado: (2022)

miR‐302b regulates cell cycles by targeting CDK2 via ERK signaling pathway in gastric cancer
por: Liu, Fu‐Yun, et al.
Publicado: (2016)

LncRNA Sox2ot modulates the progression of thoracic aortic aneurysm by regulating miR-330-5p/Myh11
por: Xiao, Weizhang, et al.
Publicado: (2020)

LncRNA LINC01503 aggravates the progression of cervical cancer through sponging miR-342-3p to mediate FXYD3 expression
por: Peng, Xing, et al.
Publicado: (2020)

MiR‐372‐3p promotes cell growth and metastasis by targeting FGF9 in lung squamous cell carcinoma
por: Wang, Qing, et al.
Publicado: (2017)

miR-125 inhibits colorectal cancer proliferation and invasion by targeting TAZ
por: Yang, Meiyuan, et al.
Publicado: (2019)

Prognostic value of miR-142 in solid tumors: a meta-analysis
por: Liu, Rongqiang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ka395ojjv04bdv1slph7a4nigv